Dry Powder Inhaler Market
Dry Powder Inhaler Market Study by Capsule-based, Blister-based, and Reservoir/Cartridge-based Devices for Bronchitis, Chronic Obstructive Pulmonary Diseases, and Asthma from 2024 to 2034
Analysis of Dry Powder Inhaler Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Dry Powder Inhaler Market Outlook (2024 to 2034)
As revealed in the detailed study by Fact.MR, the global dry powder inhaler (DPI) market is calculated at US$ 1.1 billion in 2024 and is forecasted to advance at a CAGR of 7.2% to reach a valuation of US$ 2.2 billion by 2034-end.
The rising prevalence of different types of respiratory diseases, including cystic fibrosis, chronic obstructive pulmonary diseases (COPD), and asthma is anticipated to increase demand for dry powder inhalers. Increasing demand for more efficient inhalation therapies is projected to positively impact sales of dry powder inhalers. DPIs come with more advantages compared to conventional inhalers, including nebulizers and MDIs (metered-dose inhalers). These advantages include reduced environmental impacts, ease of use, absence of liquids or propellants, and portability, which increase their adoption among healthcare professionals.
The increasing population of geriatric people, especially in developed countries, is contributing to the growing adoption of dry powder inhalers. Elderly people are more prone to different types of respiratory diseases, which leads to inhalation therapy adoption.
- North America is forecast to account for a 24.3% share of global market revenue by 2034-end.
- Demand for dry powder inhalers in South Korea is projected to accelerate at a CAGR of 8% from 2024 to 2034.
- Worldwide sales of capsule-based devices are projected to rise at a CAGR of 7.7% and reach US$ 660.7 million by 2034.
Growing emphasis on preventive healthcare measures around the world, such as effective management and diagnosis of respiratory diseases, is anticipated to increase demand for dry powder inhalers. They are used in preventive care by offering targeted drug delivery to the lungs, thus minimizing exacerbations and improving overall health outcomes.
Government initiatives aiming to improve respiratory healthcare infrastructure, ensure access to affordable inhalation therapies, and increase awareness of respiratory diseases are projected to increase the adoption of numerous respiratory devices, including respiratory protection equipment, digital respiratory devices, etc. Growing preferences for non-invasive treatment options compared to invasive ones offer an effective way to administer medication directly to our lungs.
| Report Attributes | Details |
|---|---|
| Dry Powder Inhaler Market Size (2024E) | US$ 1.1 Billion |
| Forecasted Market Value (2034F) | US$ 2.2 Billion |
| Global Market Growth Rate (2024 to 2034) | 7.2% CAGR |
| Japan Market Growth Rate (2024 to 2034) | 7.7% CAGR |
| East Asia Market Share (2034F) | 23.1% |
| Asthma Segment Market Share (2034F) | 28.1% |
| Key Companies Profiled |
|
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What is the Key Catalyst Driving Demand for Dry Powder Inhalers?
“Rising Cases of Respiratory Diseases across the World”
Increasing cases of respiratory diseases, including COPD, cystic fibrosis, and asthma are projected to contribute to the rising demand for dry powder inhalers. Genetic predispositions, aging populations, lifestyle changes, and environmental pollutants are estimated to contribute to the growing cases of these respiratory conditions.
With rising respiratory diseases an increased demand for effective treatment modalities is also encountered. Inhalation therapies, for instance, dry powder inhalers, etc., offer effective medications to the lungs, maximizing therapeutic effectiveness while reducing systemic side effects. They are estimated to enhance lung function, reduce the frequency of exacerbations, and improve symptom control.
Owing to the increasing burden of respiratory diseases along with their associated healthcare burden, an increased requirement for innovative solutions is encountered to address these challenges.
Why is Demand Growth for Dry Powder Inhalers Restrained to Some Level?
“Implementation of Stringent Regulations Creating Challenges for Product Approvals”
Implementation of stringent regulations for getting approvals for the quality check of dry powder inhalers is anticipated to create challenges for manufacturers. It becomes challenging for new players to match the set regulations established for the quality check of products, which is anticipated to adversely impact market growth.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
How are Startups Securing a Position for Themselves in This Market Landscape?
“Technological Advancements in DPI Technology”
Constant technological advancements taking place in the technology used in dry powder inhalers, such as improvements in device design, formulation techniques, and manufacturing processes are projected to increase their demand. These advancements are projected to lead to more effective drug delivery, improved therapeutic outcomes, and enhanced patient compliance.
Country-wise Insights
North America is projected to account for 23.4% of the dry powder inhaler market share by 2034, as stated in the research report published by Fact.MR, a market research and competitive intelligence provider. Moreover, the presence of a well-developed healthcare infrastructure in North America is forecast to increase dry powder inhaler demand.
What Makes the United States a Key Market for Dry Powder Inhaler Suppliers?
“Market Benefiting from Presence of Well-established Healthcare Infrastructure”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 116.9 Million |
| Growth Rate (2024 to 2034) | 7.6% CAGR |
| Projected Value (2034F) | US$ 244 Million |
The United States is estimated to hold a 45.6% share of the North American market revenue by the end of 2034. The growth is owing to the presence of a well-developed healthcare infrastructure, which is contributing to the sales of dry powder inhalers. In addition, the presence of some of the market players and their involvement in R&D activities for product advancements is also driving dry powder inhaler market growth in the country. In addition, the growing prevalence of asthma and similar respiratory diseases is estimated to contribute to the demand for dry powder inhalers.
What is Set to Help Dry Powder Inhaler Suppliers in China?
“Growing Expenditure on Healthcare and Related Facilities”
| Attribute | China |
|---|---|
| Market Value (2024E) | US$ 120.4 Million |
| Growth Rate (2024 to 2034) | 7.2% CAGR |
| Projected Value (2034F) | US$ 241.6 Million |
China is estimated to contribute 47.5% of the East Asian market share by 2034. Growing expenditure on healthcare along with advancing infrastructure facilities is forecast to contribute to market growth in the country. Moreover, the rising population of elderly people is anticipated to increase demand for dry powder inhalers to cure increasing respiratory diseases.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Category-wise Insights
Capsule-based devices are comparatively easy to use owing to their user-friendly process and minimal complexities in the assembly of medications. Therefore, capsule-based DPIs are more suitable for patients with limited dexterity.
Why Do More Patients Opt for Capsule-based Dry Powder Inhalers?
“Reduced Risks of Moisture Exposure Increasing Reliability of Capsule-based Devices”
| Attribute | Capsule-based Devices |
|---|---|
| Segment Value (2024E) | US$ 315.4 Million |
| Growth Rate (2024 to 2034) | 7.7% CAGR |
| Projected Value (2034F) | US$ 660.7 Million |
Capsule-based dry powder inhalers are set to contribute 30% share of global market revenue by the end of 2034. The rising demand for capsule-based devices is attributed to the increasing number of manufacturers providing a wide variety of products. These devices minimize the risks of moisture exposure, which is otherwise projected to degrade the efficacy and stability of medication. In addition, increasing preference and adoption of these devices by more patients and healthcare providers is also estimated to positively influence dry powder inhaler market trends.
What is the Contribution of Hospital Pharmacies Global Dry Powder Inhaler Market Expansion?
“Increasing Count of Hospital Pharmacies Ensuring Ample Supply of Dry Powder Inhalers”
The increasing count of hospital pharmacies in numerous countries, including China, India, Brazil, etc., is estimated to ensure the easy availability of dry powder inhalers. In addition, growing prescription for these devices by healthcare providers for respiratory issues is forecasted to contribute to the expansion of the dry powder inhaler market size.
Competitive Landscape
The global market is fragmented with the presence of various regional as well as global players. Partnerships, acquisitions, expansions, mergers, etc., are some of the strategic approaches adopted by prominent companies to create a huge customer base and upscale market presence. New product development, ensuring quality control, and managing supply chain systems are some of the initiatives taken by players to secure a position for themselves.
Key players in the dry powder inhaler industry are Boehringer Ingelheim GmbH, Respira Therapeutics, Inc., AstraZeneca, Teva, GlaxoSmithKline Plc., OPKO, Vectura Group Plc., 3M, Hovione, Cipla, Otsuka Pharmaceutical Co. Ltd., Cheisi, and Norton Healthcare.
Segmentation of Dry Powder Inhaler Market Research
-
By Product Type :
- Capsule-based Devices
- Blister-based Devices
- Reservoir/Cartridge-based Devices
-
By Application :
- Bronchitis
- Chronic Obstructive Pulmonary Diseases (COPD)
- Asthma
-
By Sales Channel :
- Offline Channels
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- Online Channels
-
By Region :
- North America
- Europe
- East Asia
- Latin America
- Middle East & Africa
- South Asia & Oceania
- FAQs -
How big is the size of the dry powder inhaler market in 2024?
The global dry powder inhaler market is poised to reach a value of US$ 1.1 billion in 2024.
What is the demand projection for dry powder inhalers for 2034?
Worldwide demand for dry powder inhalers is forecasted to reach a market value of US$ 2.2 billion by 2034-end.
At what rate is the demand for dry powder inhalers projected to increase?
The market for dry powder inhalers is projected to expand at 7.2% CAGR from 2024 to 2034.
What is the contribution of North America to global market revenue?
North America is set to account for 24.3% share of the global market by the end of 2034.
What is the demand outlook for dry powder inhalers in South Korea?
Sales of dry powder inhalers in South Korea are forecasted to rise at a CAGR of 8% from 2024 to 2034.
What is projected for capsule-based dry powder inhalers?
Demand for capsule-based devices is approximated to reach a market value of US$ 660.7 million by 2034.
Dry Powder Inhaler Market
*Mail attachment includes 110 figures & 134 tables